Table 3.
Patient outcome and hospital costs for patients with bloodstream infection treated using routine medical management with or without the SeptiFast test*
| Routine management (Mean ± SD) |
Routine management plus SeptiFast (Mean ± SD) |
p value | |
|---|---|---|---|
| 28-day mortality | 13 (27%) | 14 (26%) | n.s. |
| 6-month mortality | 20 (37%) | 20 (41.6%) | n.s. |
| Stay in ICU | 31.0 ± 19.4 | 22.9 ± 29.9 | <0.05 |
| Stay in hospital | 21.3 ± 23.4 | 18.3 ± 21.4 | <0.05 |
| Stay in ICU survivors | 24.1 ± 21.9 | 18.3 ± 11.4 | <0.05 |
| Number of antibiotics used per patient | 5.1 ± 3.1 | 4.2 ± 2.2 | <0.05 |
| Antibiotic treatment cost per patient | 3576 € | 2812 € | <0.05 |
| Cost of ICU stay | 32798 € | 24246 € | <0.05 |
| Cost of ward stay | 5824 € | 4988 € | <0.05 |
| Total cost | 42198 € | 32228 € | <0.05 |
| n.s., not significant *Modified after ref. [17] | |||